Los Angeles, CA -- (SBWire) -- 04/10/2019 --Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig's disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig's disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die. According to Centers for Disease Control and Prevention (CDC), 14,000 - 15,000 Americans had ALS in 2016.

The classification of Amyotrophic Lateral Sclerosis (ALS) Treatment includes Riluzole, Edaravone (Radicava) and Other and the proportion of Edaravone (Radicava) in 2017 is about 67.7%, Radicava is approved in Japan and Korea in 2015, and through the FDA in 2017.

In 2018, the global Amyotrophic Lateral Sclerosis (ALS) Treatment market size was 240 million US$ and it is expected to reach 380 million US$ by the end of 2025, with a CAGR of 6.9% between 2019 and 2025.

This report studies the Amyotrophic Lateral Sclerosis (ALS) Treatment market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1076627/global-amyotrophic-lateral-sclerosis-als-treatment-market

This report focuses on the global top players, covered

Mitsubishi Tanabe Pharma

Sanofi

Mylan Pharma

Apotex

Glemark Generics

Covis Pharma

Sun Pharma

Lunan Pharma

Market segment by Regions/Countries, this report covers

North America

Europe

China

Rest of Asia Pacific

Central & South America

Middle East & Africa

Market segment by Type, the product can be split into

Riluzole

Edaravone (Radicava)

Other

Market segment by Application, the market can be split into

Hospital

Drugs Store

Other

Get Full Report Now at USD 2,900 @ https://www.qyresearch.com/settlement/pre/1d59a73f2df17c5cce8df27bbf8e5724,0,1,Global%20Amyotrophic%20Lateral%20Sclerosis%20(ALS)%20Treatment%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Companies,%20Key%20Regions,%20Types%20and%20Application

The study objectives of this report are:

To study and forecast the market size of Amyotrophic Lateral Sclerosis (ALS) Treatment in global market.

To analyze the global key players, SWOT analysis, value and global market share for top players.

To define, describe and forecast the market by type, end use and region.

To analyze and compare the market status and forecast among global major regions.

To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis (ALS) Treatment are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.